Ainos, Inc. (NASDAQ:AIMDW – Get Free Report) saw a significant decrease in short interest in September. As of September 15th, there was short interest totaling 1,998 shares, a decrease of 43.8% from the August 31st total of 3,558 shares. Based on an average trading volume of 1,181 shares, the short-interest ratio is currently 1.7 days.
Ainos Stock Down 20.9%
Shares of AIMDW opened at $0.07 on Wednesday. The stock has a 50 day moving average of $0.09 and a 200 day moving average of $0.10. Ainos has a 12 month low of $0.05 and a 12 month high of $0.27.
About Ainos
Ainos, Inc is a healthcare company focused on developing technologies and products for point-of-care diagnostics and therapeutic applications. The company’s work centers on artificial-intelligence-enabled testing, low-dose interferon therapies and cannabinoid-based treatments.
Ainos is developing its AI Nose platform, which is designed to analyze volatile organic compounds and support rapid, point-of-care testing. The company has also pursued diagnostic applications for respiratory conditions and other health areas, with the goal of providing testing outside traditional laboratory settings.
In therapeutics, Ainos has worked on low-dose interferon products and novel cannabinoid-based treatments for selected medical conditions.
Further Reading
- Five stocks we like better than Ainos
- Up All Night: How Nasdaq’s 23-Hour Trading Could Wake Up Wall Street
- 4 Stocks That Could Split Next—and Why Investors Are Watching
- Oura’s IPO Freeze Isn’t the Warning Sign It Looks Like
- Bitcoin Is Bouncing Back—Here are 2 Ways to Play the Rebound
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
